Kleo Pharmaceuticals Inc. Licenses Intellectual Property From Yale University Related to Targeted Immunotherapies
Kleo Pharmaceuticals Inc. Secures Series A Funding to Advance the Development of Antibody Recruiting Molecules (ARMs) and Synthetic Antibody Mimics (SyAMs)
Long Acting Growth Hormone Based on Amunix' XTEN(R) Technology Completes Enrollment of Phase 3 Trial
U.S. Home Loan Originations Decrease 4 Percent in Q2 2016 Despite Rise in Purchase and HELOC Originations
SLUSH PUPPiE Nominated for 2016 Madison Avenue Walk of Fame
ISO Invites Media to Attend Stakeholder Symposium, Sept. 7 & 8
Avista Makes Annual Price Adjustment Requests in Washington
Indoor Cycling Group Joins Life Fitness Family
Horace Mann Executive Leadership to Participate in KBW 2016 Insurance Conference on September 7, 2016
BLVD Treatment Centers and Award-Winning Poet Natalie Patterson Launch "I Know Someone" to Combat Addiction on International Overdose Awareness Day
Conteúdo reproduzido sob licença da Globe Newswire Inc.